Thematics Asset Management Decreases Holdings in Mettler-Toledo International, Inc. $MTD

Thematics Asset Management lowered its position in Mettler-Toledo International, Inc. (NYSE:MTD) by 64.3% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 3,901 shares of the medical instruments supplier’s stock after selling 7,029 shares during the period. Thematics Asset Management’s holdings in Mettler-Toledo International were worth $4,789,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the company. Vanguard Group Inc. increased its position in shares of Mettler-Toledo International by 1.3% in the third quarter. Vanguard Group Inc. now owns 2,591,173 shares of the medical instruments supplier’s stock valued at $3,180,950,000 after buying an additional 34,466 shares in the last quarter. Capital International Investors grew its stake in Mettler-Toledo International by 1.2% in the 3rd quarter. Capital International Investors now owns 859,559 shares of the medical instruments supplier’s stock valued at $1,055,203,000 after acquiring an additional 10,395 shares during the last quarter. Alliancebernstein L.P. increased its holdings in Mettler-Toledo International by 1.1% during the 2nd quarter. Alliancebernstein L.P. now owns 717,449 shares of the medical instruments supplier’s stock valued at $842,802,000 after acquiring an additional 8,121 shares in the last quarter. Geode Capital Management LLC raised its position in Mettler-Toledo International by 0.6% during the second quarter. Geode Capital Management LLC now owns 581,847 shares of the medical instruments supplier’s stock worth $681,489,000 after acquiring an additional 3,383 shares during the last quarter. Finally, Norges Bank acquired a new position in Mettler-Toledo International during the second quarter worth about $360,126,000. 95.07% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several research firms have recently commented on MTD. Bank of America upgraded shares of Mettler-Toledo International from a “neutral” rating to a “buy” rating and set a $1,600.00 price target on the stock in a research report on Monday, December 15th. Wells Fargo & Company lifted their price objective on Mettler-Toledo International from $1,400.00 to $1,450.00 and gave the stock an “equal weight” rating in a research report on Monday, December 15th. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Mettler-Toledo International in a research note on Monday, December 29th. Morgan Stanley dropped their price target on Mettler-Toledo International from $1,550.00 to $1,475.00 and set an “equal weight” rating for the company in a research report on Tuesday, February 10th. Finally, Wall Street Zen raised Mettler-Toledo International from a “hold” rating to a “buy” rating in a report on Saturday, February 14th. Six analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus price target of $1,435.42.

Mettler-Toledo International Stock Up 0.6%

Shares of NYSE:MTD opened at $1,174.59 on Friday. The company has a market cap of $23.88 billion, a P/E ratio of 27.89, a P/E/G ratio of 2.45 and a beta of 1.43. Mettler-Toledo International, Inc. has a 52 week low of $946.69 and a 52 week high of $1,525.17. The business has a fifty day simple moving average of $1,378.52 and a 200-day simple moving average of $1,367.96.

Mettler-Toledo International (NYSE:MTD) last released its earnings results on Thursday, February 5th. The medical instruments supplier reported $13.36 earnings per share for the quarter, topping the consensus estimate of $12.76 by $0.60. Mettler-Toledo International had a negative return on equity of 495.07% and a net margin of 21.59%.The firm had revenue of $1.13 billion for the quarter, compared to the consensus estimate of $1.10 billion. During the same period in the prior year, the business posted $12.41 earnings per share. The firm’s revenue for the quarter was up 8.1% compared to the same quarter last year. Mettler-Toledo International has set its Q1 2026 guidance at 8.600-8.750 EPS and its FY 2026 guidance at 46.050-46.700 EPS. Sell-side analysts expect that Mettler-Toledo International, Inc. will post 42.71 earnings per share for the current fiscal year.

Insider Activity

In related news, CFO Shawn Vadala sold 800 shares of the business’s stock in a transaction that occurred on Tuesday, February 10th. The shares were sold at an average price of $1,410.12, for a total value of $1,128,096.00. Following the completion of the sale, the chief financial officer directly owned 5,288 shares in the company, valued at approximately $7,456,714.56. The trade was a 13.14% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 1.94% of the company’s stock.

Mettler-Toledo International Profile

Mettler-Toledo International Inc is a global manufacturer and distributor of precision instruments and services for laboratory, industrial and food retail applications. The company’s product portfolio includes laboratory balances and analytical instruments, industrial weighing systems, process analytics and sensors, metal detection and x-ray inspection equipment, checkweighers, and a range of automated inspection and data-management solutions. Mettler-Toledo also provides software, calibration and lifecycle services intended to support compliance, quality control and operational efficiency across customer facilities.

The company serves a broad set of end markets including pharmaceutical and biotech laboratories, chemical and food processors, logistics and manufacturing operations, and retail environments where accurate weighing and inspection are critical.